Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.74
(
2.03%
)
Bitcoin
71,071.97
(
-0.24%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 49
Posts 5519
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: mcbio post# 82218

Tuesday, 08/11/2009 11:51:14 PM

Tuesday, August 11, 2009 11:51:14 PM

Post# of 257257
"However, the company did say that the primary focus of this new class of compounds is on "issues of resistance and overall potency." "

isn't the rationale of any new class of antiviral related to potency and/or resistance?

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now